Disodium lauroampho diacetate

miranol bm conc. ; 1h-imidazolium,1-[2-(carboxymethoxy)ethyl]-1-(carboxymethyl)-4,5-dihydro-2-undecyl-,hydroxide, disodium salt (9ci) ; empigen cdl 30/j ; carboxymethyl amphoteric imidazoline ; monateric 951a ; 1h-imidazolium, 1-2-(carboxymethoxy)ethyl-1-(carboxymethyl)-4,5-dihydro-2-undecyl-, hydroxide, disodium salt ; miranol h 2m ; rewoteric am 2l ; disodium lauroampho acetate ; 2-imidazolinium,1-[2-(carboxymethoxy)ethyl]-1-(carboxymethyl)-2-undecyl-, hydroxide, disodiumsalt (8ci) ; disodium lauroamphodiacetate ; 1-[2-(carboxymethoxy)ethyl]-1-(carboxymethyl)-2-undecyl-2-imidazoliniumhydroxide, disodium salt (6ci) ; monateric 949j ; disodium 1-[2-(carboxymethoxy)ethyl]-1-(carboxymethyl)-4,5-dihydro-2-undecyl-1h-imidazolium hydroxide ; 1h-imidazolium,1-[2-(carboxymethoxy)ethyl]-1-(carboxymethyl)-4,5-dihydro-2-undecyl-,hydroxide, sodium salt (1:1:2) ; 1h-imidazolium, 1-[2-(carboxymethoxy) ethyl]-1-(carboxymethyl)-4,5-dihydro-2-undecyl-, hydroxide, disodium salt 4,5-dihydro-2-undecyl-1h-imidazole-1-ethanol, dicarboxymethylated, disodium salt